Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
As I said earlier, looks like he still is.
The 13D long game started the day NP punted Tony C and Pestell from CYDY.
I didn't say Pestell forced the buyout of his company, although that may have possibly been a caveat for him accepting a position. Either way he benefitted.
Tony C and the board were in favor, yet you don't mention that, you lay it all on NP. The BOD voted in favor.
You asked how other shareholders in the same class would benefit, taking a hit on CYDY shares along with the rest of us, but getting a benefit elsewhere can make up for that .
I don't buy the whole 13D group said there will be no RS, no buyout of InCellDx.
They can say whatever they want, it will not be up to them, it will be up to the BOD they try to get elected in. If that happens and the new BOD appoints a new CSuite they will be the ones who make the decision as to whether to RS and whether to buy any other companies.
Right now addressing that narrative as they have to and in a very literal manner because they are shareholders and cannot make that decision , later they can state they had no control, the BOD was independent, blah,blah,blah .
Jmo
The same way that Pestell became such a large shareholder of Cytodyn stock.
Own shares in another company, force Cytodyn Mgmt to buy said company.
Oh yeah, but you would need a BOD with control to do that.
The percentages quoted are completely wrong.
When a Fund or Shareholder gets above 5% ownership they have to file a 13D.
If they go below, they have to file again stating that they are below.
In this case no one entity owned close to 5% so they banded together as a group and combined their shares under the control of One person by giving their Power of Attorney to Rosenbaum.
That's an extraordinary effort in itself. The year long FUD was another, the latest, with the coming out of the closet with renewed FUD is the proof in the pudding
If not so important, they could have sold at $10 or $7 per share and made out like bandits
Instead, they want the whole enchilada or at least the biggest portion.
Jmo
Filing an EUA is not like filling out a job application, it's not something you "just do".
It's like filing a BLA with a lot of effort and expense.
When they said looking at filing EUA it's more of exploring the possibility of whether it is worth the expense and probability of approval.
The only real chance is with a successful trial. Hopefully we get that in Brazil.
Jmo
They are not missing the message, they are pushing a false narrative to dupe existing shareholders.
If Cytodyn is such a failure, why does the 13D group desperately want control ?
Jmo
Why should he give back If Tony C and Pestell aren't forced to.
Yessir, and everybody wants to talk about NPs greed and self enrichment.
Seems to me that Tony C helped Pestell to get very rich. Paid a high price for a useless company
I don't see the 13D group and it's minions complaining about that. I'm sure that put some hurt on Cytodyn financially at a time when the share price was very low .
Jmo
You can go back to Leronlimab's intended use (HIV). Who is the competition there ?
A Gilead exec was brought in. Maybe they thought a fast track to approval would materialize with a big gun on board. Didn't happen, seem like it was a dead period. In that time a company was purchased which has turned out to be useless. This during a critical time in the company development .
Seems like CYDY was being handicapped in retrospect
Now with the 13D another ex Gilead exec pops up out of the woodwork.
Someone was behind the shorts and FUD in 2020. Now many of those, are happy to support the 13D groups takeover. Why ?
Same endgame.
Before the 13D group came out with the 13D filing, someone had posted on a forum that Gilead had bought 60 million shares . Was this the 13D group or separate from them Does Gilead have control of 120 million CYDY shares?
I think it's Gilead Sciences
NP needs to sell out to a bigger Pharma or sell some indications to bolster the war chest.
Results from NASH will bolster a big pharma partnership, LH also, on top of HIV. Success in the Brazil Trials will help.
The next 3 months will be key, and I would be scheduling the annual meeting in October/ November if I was NP.
Stall em, before you beat em.
Jmo
No, while Patterson may see it as a way to get Leronlimab under his control, for the 13D it's deeper than that.
1) The 13D needs full control to be able to really execute their plan. So need to take over the BOD.
Smarmy feel good posters and anti NP poster mix to shift investor sentiment is step 1.
2) Reverse Split to compress existing SH. Themselves included. 17 million shares at .50/sh maybe less average . So 8 million dollars spent to take over a 1 billion dollar company ?
If successful , they will not be sacrificing very much, their payday will be down the road after they minimize ours .
3) After RS, massive dilution for war chest and company development.
4) Second massive dilution to buy InCellDx and get a premium on their shares there which will make up for taking a hit on Original CYDY shares.
5) Instead of owning 5 or 6 percent of a 1 billion dollar company, they will own 55 to 60 percent for maybe a total investment of 50 million dollars. This is including their investment in InCellDx. It could be more or less, who knows.
6) Selling for 1 billion they net maybe 600 million dollars, sell for 2 Billion they net over 1 billion.
Us retail who have been compressed 1 for 10, might end up flat or with a 50% or more loss after the company is sold. Depends on our average cost basis.
Amazing that such a small amount of money will be able to leverage such a large % of the pie.
That's what a company purchase will do, it's been done to Cytodyn once, the largest owner of shares got them by selling a worthless company to Cytodyn.
Tony C did it once to Cytodyn shareholders, now looking to complete the 2nd fleecing of Cytodyn shareholders.
Jmo
That would be because NP and Kelly are employees. They receive stock options as a part of their compensation package.
This is normal in many Corporations across the US.
The 13D Group had to buy because they are not employees. Very simple.
You do understand that a rolling review is when a company is allowed to submit a BLA in its various sections as a company completes each section. This is instead of submitting the entire BLA at once.
People think that the FDA is reviewing each piece as it is received and accepting, but this is not necessarily the case, the FDA will not accept the BLA until after the whole thing has been submitted and it still takes a while to hear back about acceptance and then get a PDUFA date. After that point and after the BLA has been reviewed they can still get a CRL or an FDA approval.
jmo
So far no plan, just more NP bashing as if we aren't deafened to that reading it over and over here and other platforms.
In case the 13D group doesn't get it, we see that in order to support their agenda they helped basher shorts kill our SP.
If you want to see CYDY shareholders future after the RS, then the dilution to buy InCellDx, then a sale of the whole enchilada. See below.
There is a company on the OTC with the ticker SGSI.
They have been in many different businesses. However, the "Owners" have been running a model of RS, dilute, Buy new companies over and over.
While the shareholders were screwed , the owners seemed to come up smelling like roses. Oh but wait , the owners also owned or partly owned the companies purchased. Sound Familiar ?
Jmo
Yet that management took a product and has proven how valuable it is to the world and that is the only reason the 13D group came together isn't it ?
To try to take control of a molecule the inept management dusted off and proved out.
Not something that the 13D group did, not something the original owner did , but something that was completed by the current management and which continues to be proven out.
Current management will have some indications sold before the 13D group get close to getting their hands on the steering wheel. Maybe the whole company .
Unfortunately that little act will be something that was precipitated by those arrogant 13D investors and it will probably not be sold the the BP that they are in league with.
Jmo
Yes they are the reason, however they are supported by the fact that Cytodyn gets slow rolled by every Country they attempt to operate in.
Unless we get a surprise deal with a BP for a partnership or a Buyout we will have a large time window with no positive catalysts.
I am planning to average down but will not do so unless this goes to a dollar or less.
The best thing NP and crew can do is sell a stake in the company or sell an indication or three to get a money infusion. They recognize that fact and are working towards something so at least it's in process.
This can be an amazing company in a couple of years, however they need to be a part of the club , they tried to buck the system and it did not work.
So, HIV or LH or both , for autonomy in the other indications.
I saw the urgency in the group in yesterday's call, so hopefully they can take the two indications with lots of data and make a deal.
Jmo
Brazil was barely mentioned. They have been delayed, probably in the hope that COVID will be burned out by the fall.
India - not mentioned at all. They have been shut down there.
Philippines - done and nothing.
Canada - nothing
UK - Nothing
Now we are back to the USA and LH. Hopefully they have great data and can use it to sell Cytodyn to a BP for at least 10 a share.
jmo
They need to sell Cytodyn while they still have some semblance of control.
jmo
It's a small chance, but these guys have not given up yet.
Recknor stated on a CC that they want to do a Phase 2 B trial for LH.
If they are would be a good question for the CC.
That's too bad for NP.
One of the things that might have saved him and others was an interim readout that would be positive before the annual meeting.
If delayed till the fall the 13D group may win whatever proxy votes they put on the table.
Jmo
The reason they will do well is that if they get control they will reverse split it to cut current shareholders piece down.
Then they will dilute to purchase IncellDX. Which they have ownership into. How much? is the question.
All of the InCellDX stock will be treated at a premium and since done after the reverse will give them a much larger portion of the the Pie.
They can then sell it and get the deal premiums for themselves with their expanded ownership from the InCellDX purchase.
Jmo
Yup, and this way we the current shareholders get the benefit of it and NP can choose who he wants to get control of Leronlimab.
NP should sell Cytodyn before the 13D group gets a chance to follow through with their plan.
Interesting change I just noticed on the XNRGI website.
The management Pages were updated. Ashish Nanda, the guy who initiated the "going dark" as a part of his stock purchase contract seems to be the Chairman of the Board.
The White papers also appear to have been updated. The Updated version of XNRGI New Battery Architecture has this at the bottom of each page.
Yup, tedious is the best description.
It's the reason I am paying less and less attention to any of these forums.
The 13D group and it's supporters are now lumped in with the AF crew on my book.
Jmo
NP also mentioned in the last Proactive video that they were currently in talks with a large European distributor.
They are seeing great results from proper dosing and expect to see the same from the Brazil trials. With a passing P-Value they will be giving all regulatory agencies what is required and be set up for distribution where needed.
This will serve them in the later commercialization in LH.
Jmo
You don't understand sarcasm ?
Buddy boy as you said, exponential.
This is in one country . At some point this will go exponential in many countries.
As Brazil trials crank up and then we get the interim results this will get very interesting.
Those that like to play Devil's Advocate and claim that nothing short of P-Value in a structured trial that is Randomized, blinded double placebo with a decent trial size will be without an argument.
In case nobody noticed, those failed trials CD10 and CD12 showed Cytodyn how to most effectively apply LL as a Covid treatment .
Jmo
This PR is only problematic for enemies of CYDY or the group wanting to take control to throw the other shareholders and management under the bus for their gain.
Yes there will be more PRs like this both from Brazil and India.
The false narrative that Cytodyn was toast in the Philippines has been shot down.
NPs statement of being revenue producing came true . We know over 100 treated in the Philippines and they wanted more
More is being sent and will be paid for.
This story will happen over and over to the chagrin of shorts and also the 13d group, and especially big pharma.
Jmo
Watching the last video from the Philippines yesterday.
I think the most important and telling portion was when they talked about Hemoabsorption.
Two patients were on treatment from Cytosorb, which is used to filter Cytokines from the blood.
They also filtered out the LL.
Patients got worse.
Got them off the filter , gave them a second shot and they got better.
Night and day effect.
LL given and improving, filter out LL get worse, LL given again and filter removed and immediate improvement.
Jmo
You also don't have a life saving molecule that is saving lives, improving outcomes and garnering more attention.
Oh yeah, name calling the CEO as if it will have an effect on stock purchases.
The negative flow of opinion and diatribes are designed to stem stock purchases which combined with short sells create an even more negative environment.
It looks like they threw everything they had at it, including the myth that LL was dead in the Philippines due to US FDA influence.
Whoops !
Jmo
You would not announce a shipping contract to ship one batch.
This will provide a constant flow of LL to the Philippines.
The more it gets used, the more lives it saves.
The more lives that are saved, the more it gets used.
This will keep increasing, started with 1, then 28, then 100 patients , now it is being sold.
Jmo
Sorry , meant Yahoo finance it any other stock platform where you can get quotes and news.
There are many ambulance chaser law firms chasing those 2 stocks .
All you have to do is aim them at XNRGI I am sure you can easily get enough investors who have lost money for a class action.
Yes, and they may have made a side deal to influence a buyout, with their block being bought at a premium by BP.
However, by the time they can get a vote to even get a board seat, much less replace anybody. The LH results will be known, the Brazil trials interim might be known and will affect voting and price.
The LH results will be a huge factor because of the potential future market , nothing can be completed towards a buyout in a month so the results there will drive opinion on a potential buyout .
Jmo
Yeah, yeah . The Flea on the tail doesn't sell the Dog.
I'm not against a buyout. But this month before the Longhaulers results , my price is 15/ sh , anything above that is also acceptable.
Once LH results in, if good, 30/sh minimum because they will need 2 more trials. But if results are good then LH is a huge opportunity.
In August If interim from Brazil good to great it's 60 / sh to 150/ sh.
My point is , Gilead will not want to pay those prices and I am sure my prices are lower than what other shareholders will want.
So the 13d group doesn't have financial clout, the share clout, or the influence clout to negotiate or direct a sale.
I understand more than some, who try to stir excitement or any other emotion from nothing.
Jmo
He showed data for those 4 patients because those were patients that he actually treated himself.
More false narratives.
The 13D group does not have that kind of money. They cant even swing a vote to accept a tender offer from a BP, at least not for the low price a BP would be willing to pay.
jmo
Go to the YMB for CCIV or SOS, in the news sections there are PRs for lots of ambulance chaser law firms looking for lead plantiffs for class action lawsuits where investors have lost money.
They are everywhere these days. If that is what you want to do.
Not gonna happen.